Serum levels of neutrophil activation cytokines in Kawasaki disease-Reference-Cited by-同舟云学术

Serum levels of neutrophil activation cytokines in Kawasaki disease

Published:2001-04-06 Issue:2 Volume:43 Page:115-119
ISSN:1328-8067
Container-title:Pediatrics International
language:en
Short-container-title:Pediatr Int

Author:

Suzuki Hiroyuki,Noda Eisaku,Miyawaki Masakazu,Takeuchi Takashi,Uemura Shigeru,Koike Michio

Publisher

Wiley

Subject

Pediatrics, Perinatology, and Child Health

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1442-200x.2001.01362.x/fullpdf

Reference32 articles.

1. HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN FOR KAWASAKI DISEASE

2. The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin

3. 4 H Suzuki, T Iizuka, S Uemura, M Koike, and J. Maeda The pathophysiological significance of serum tumor necrosis factor in Kawasaki disease. In: Kawasaki T (ed.).Proceedings of the Third International Kawasaki Disease Symposium, 29 November-2 December, 1998, Tokyo, Japan. Japan Heart Foundation, Tokyo, 1988; 117-19.

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune response to intravenous immunoglobulin in patients with Kawasaki disease and MIS-C;Journal of Clinical Investigation;2021-10-15

2. Effect of Activin A on activation status of monocytes in acute-phase Kawasaki disease;Clinical and Experimental Medicine;2021-02-25

3. Activin a suppresses peripheral CD8+ T lymphocyte activity in acute-phase Kawasaki disease;BMC Immunology;2021-02-23

4. Sivelestat sodium hydrate treatment for refractory Kawasaki disease;Pediatrics International;2019-05

5. White Blood Cell and Neutrophil Counts and Response to Intravenous Immunoglobulin in Kawasaki Disease;Global Pediatric Health;2019-01